Cand.scient. Ana Slipicevic - from Vivi Ann Flørenes's group at the Division of Pathology - will give her trial lecture on the subject "Dysregulation of apoptosis in cancer. An update" on Tuesday May 4th at 15.15.
She will defend her PhD thesis - entitled "Studies of the PI3K/Akt and MAPK/ERK1/2 signaling pathways: identification of novel downstream targets involved in development and progression of melanoma" at 10.15 on Wednesday May 5th.
Venue for both events: Auditorium (BU1), Radiumhospitalet, Montebello, Oslo
From major journals, first or last author from the Institute for Cancer Research
Diacylglycerol kinase and phospholipase D inhibitors alter the cellular lipidome and endosomal sorting towards the Golgi apparatus
Cell Mol Life Sci (in press)
The role of lipid species in membranes and cancer-related changes
Cancer Metastasis Rev
Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity
Clin Cancer Res (in press)